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Introduction 
The toxicity of furan is known to rely on its selective oxidation in the liver by Cyt P450 
enzymes transforming it into the very reactive butenedial, which quickly reacts with 
proximate nucleophiles of DNA (Figure 1) and proteins. [1] This principle was used in our 
laboratory to develop a high yielding DNA interstrand crosslinking methodology. [2] 
 
 
Figure 1. Furan oxidation and reaction with nucleophilic DNA 
 
In view of the demonstrated site-selectivity, the method further holds promise for site-
specific crosslinking of proteins to their DNA recognition site, which is highly relevant in 
the study of transient protein-DNA interactions. Furthermore irreversible DNA binding can 
be achieved through such a covalent linkage, which is potentially useful for new generation 
therapeutics. [3]
 
 
Results and Discussion 
In our previous studies a good major groove binding peptide was found to be prerequisite 
for such crosslinking experiments to ensure proximity between the reactive enal and the 
attacking nucleophile. [4] Therefore we chose to work with a miniature transcription factor, 
to allow for easy modification and analysis. The experiments were carried out with a non-
covalent GCN4 mimicking dimer, earlier described by Morii et al. (Figure 2). [5] 
 Figure 2. Principle of the crosslinking from furan-modified protein mimic to DNA  
 
Furylalanine was introduced in the peptide by replacing a lysine (K231) or alanine (A239) 
residue positioned in the major groove, as determined from the crystal structure. [6] 
Binding of these modified protein mimics was ensured by the generation of heterodimers 
and verified by EMSA experiments. Optimization of the oxidation conditions was carried 
out by reaction with hydrazine and monitoring on HPLC. However, furan oxidation in the 
presence or just before the addition of DNA, did not result in observable crosslink 
formation. Although unfavorable positioning and/or linking cannot be excluded, we believe 
that the involvement of the available nucleophilic amine functionalities of the DNA in 
Watson-Crick basepairing, renders them unreactive towards the crosslinking reaction. This 
rationale is further supported by the described use of aldehydes for the detection of single 
stranded regions of DNA [7] and their use to elucidate RNA folding pathways. [8] 
We are currently exploring the reverse approach, incorporating the furan moiety into DNA, 
for further crosslinking to a non-modified protein mimic.  
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